TipRanks
Go Ultimate55% OFF

China SXT Pharmaceuticals (2RY3) Cash flow

China SXT Pharmaceuticals Cash Flow

DE:2RY3's free cash flow for Q4 2026 was $-2.26M. For the 2026 fiscal year, DE:2RY3's free cash flow was increased by $0.00 and operating cash flow was $-2.26M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowMar 26Mar 25Mar 24Mar 23Mar 22
$ -4.02M$ -2.35M$ -1.93M$ -80.76K$ -2.37M
$ -1.25M$ 63.52K$ 26.42K$ -12.30K$ -46.91K
$ 14.43M$ 8.40M$ -2.62M$ 2.94M$ 1.63M
$ 28.18M$ 18.13M$ 12.08M$ 17.37M$ 12.96M
$ -4.02M$ -2.35M$ -1.94M$ -151.44K$ -2.44M

Currency in USD

China SXT Pharmaceuticals Cash Flow

-10M-5M05M10M15M20M2017201820192020202120222023202420252026OperatingInvestingFinancing